The Global Cannabis Regulatory Summit 2026 is not an open industry conference, but an invitation-only working meeting for regulatory authorities, policy experts, patient representatives, and researchers. From April 19-21, delegations from more than 30 countries will gather in London – from Canada to Australia to several EU states, including Germany – to explore pathways toward international cannabis standards. The focus will be on patient safety, public health protection, and balancing medical, recreational, and industrial market development.
What to Expect
The summit combines formal symposium structure with intensive dialogue. It kicks off with a Welcome Reception on the evening of April 19, followed by a networking dinner on April 20. The two-day symposium itself takes place on April 20-21 and combines panels, fireside chats, and interactive workshops.
In terms of content, the summit builds on the White Paper Book published in 2025. The two central guiding principles are Standards and Responsibility. Specific topics include:
- GMP comparability across countries
- Pharmacovigilance surveillance and quality control
- Import and export corridors
- Advertising and youth protection regulations
- Recognition of national licensing frameworks
The target audience includes regulators, government representatives, patient organizations, public health professionals, and selected representatives from industry and research. The focus is on practical harmonization, not sales promotion.
Location and Travel
The summit takes place in London. The exact venue is communicated only to invited delegates and is subject to confidentiality. London is accessible via airports such as Heathrow, Gatwick, and Stansted; the city has an extensive public transport network (Underground, buses, trains). Those traveling from Germany, Austria, or Switzerland can also fly or take the Eurostar train via Brussels or Amsterdam.
Tickets and Pricing
The summit is a closed event by invitation only. There is no public ticket booking. Interested regulatory authorities, research institutions, or patient organizations can submit participation requests directly to the organizers. Contact: events@cannabisregsummit.com.
Why This Event?
The Global Cannabis Regulatory Summit addresses a core challenge in international cannabis regulation: while individual countries develop their own frameworks – from Germany’s partial legalization to Switzerland’s pilot phase – there is a lack of coordinated standards. This creates barriers to recognition, import/export, and research cooperation.
This 2026 edition is relevant because it builds on the findings of the 2025 White Paper and aims to establish concrete action steps for the coming years. For the DACH region, this means: decisions will be made here about whether national licenses will be internationally recognized – a decisive factor for patients, researchers, and companies.
Unlike trade shows or networking conferences, the summit is a working meeting among equals. It’s about genuine harmonization, not sales. This makes it attractive for professionals from government and science, even though participation is limited.
